Cabaletta Bio, Inc. (CABA) stock forecast and price target
Price $1.28 · data as of November 13, 2026
12-month price target
Average target$11.75
Upside / downside+818.0%
Analysts8
ConsensusStrong buy
Low $3.00Average $11.75High $20.00
Gold marker: average target · white marker: today’s price ($1.28)
Analyst ratings
Strong buy 1Buy 7Hold 2Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.29 | +38.7% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.13 | +12.5% | $0 |
| Next quarter ends December 31, 2026 | $-0.28 | +29.3% | $0 |
| Quarter after ends March 31, 2027 | $-0.28 | +28.7% | $0 |
Consensus of the analysts covering Cabaletta Bio, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Cabaletta Bio stock price target?
The average 12-month target from 8 analysts is $11.75, 818.0% above the current price of $1.28 Targets range from $3.00 to $20.00.
Is Cabaletta Bio a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 7 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Cabaletta Bio expected to earn?
Analysts expect EPS of $-1.29 for the fiscal year ending December 31, 2026 and $-1.13 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.